Works matching DE "MORPHINE derivatives"

Results: 123

Gram-Scale Enantioselective Formal Synthesis of Morphine through an ortho-para Oxidative Phenolic Coupling Strategy.

Published in:

Angewandte Chemie, 2014, v. 126, n. 49, p. 13716, doi. 10.1002/ange.201408435

By:

Tissot, Matthieu;
Phipps, Robert J.;
Lucas, Catherine;
Leon, Rafael M.;
Pace, Robert D. M.;
Ngouansavanh, Tifelle;
Gaunt, Matthew J.

Publication type:

Article

Population pharmacokinetics of buprenorphine following a two-stage intravenous infusion in healthy volunteers.

Published in:

European Journal of Clinical Pharmacology, 2007, v. 63, n. 12, p. 1153, doi. 10.1007/s00228-007-0377-2

By:

Jensen, Mette L.;
Foster, David J. R.;
Upton, Richard N.;
Kristensen, Kim;
Hansen, Steen H.;
Jensen, Niels-Henrik;
Nielsen, Bettina N.;
Skram, Ulrik;
Villesen, Hanne H.;
Christrup, Lona

Publication type:

Article

Side-effects of analgesic kyotorphin derivatives: advantages over clinical opioid drugs.

Published in:

Amino Acids, 2013, v. 45, n. 1, p. 171, doi. 10.1007/s00726-013-1484-2

By:

Ribeiro, Marta;
Santos, Sónia;
Sousa, David;
Oliveira, Margarida;
Santos, Sara;
Heras, Montserrat;
Bardaji, Eduard;
Tavares, Isaura;
Castanho, Miguel

Publication type:

Article

Treatment Outcome for Flexible Dosing Buprenorphine Maintenance Treatment.

Published in:

American Journal of Drug & Alcohol Abuse, 2012, v. 38, n. 2, p. 155, doi. 10.3109/00952990.2011.643988

By:

Fareed, Ayman;
Vayalapalli, Sreedevi;
Casarella, Jennifer;
Drexler, Karen

Publication type:

Article

Brief vs. Extended Buprenorphine Detoxification in a Community Treatment Program: Engagement and Short-Term Outcomes.

Published in:

American Journal of Drug & Alcohol Abuse, 2009, v. 35, n. 2, p. 63, doi. 10.1080/00952990802585380

By:

Katz, Elizabeth C.;
Schwartz, Robert P.;
King, Stuart;
Highfield, David A.;
O'Grady, Kevin E.;
Billings, Timothy;
Gandhi, Devang;
Weintraub, Eric;
Glovinsky, David;
Barksdale, Wardell;
Brown, Barry S.

Publication type:

Article

Lack of Reduction in Buprenorphine Injection After Introduction of Co-Formulated Buprenorphine/Naloxone to the Malaysian Market.

Published in:

American Journal of Drug & Alcohol Abuse, 2009, v. 35, n. 2, p. 68, doi. 10.1080/00952990802585406

By:

Bruce, R. Douglas;
Govindasamy, Sumathi;
Sylla, Laurie;
Kamarulzaman, Adeeba;
Altice, Frederick L.

Publication type:

Article

Behavioral counseling content for optimizing the use of buprenorphine for treatment of opioid dependence in community-based settings: a review of the empirical evidence.

Published in:

2007

By:

Copenhaver, Michael M.;
Bruce, R. Douglas;
Altice, Frederick L.

Publication type:

journal article

Treatment of heroin dependence with buprenorphine in primary care.

Published in:

2002

By:

Fiellin, David A.;
Pantalon, Michael V.;
Pakes, Juliana P.;
O'Connor, Patrick G.;
Chawarski, Marek;
Schottenfeld, Richard S.

Publication type:

journal article

Direct Synthesis of Noroxymorphone from Thebaine: Unusual Ce<sup>IV</sup> Oxidation of a Methoxydiene-Iron Complex to an Enone-γ-Nitrate.

Published in:

European Journal of Organic Chemistry, 2016, v. 2016, n. 8, p. 1500, doi. 10.1002/ejoc.201600153

By:

Machara, Ales;
Endoma‐Arias, Mary Ann A.;
Císařová, Ivana;
Cox, D. Phillip;
Hudlicky, Tomas

Publication type:

Article

Cost-Effectiveness of Long-Term Outpatient Buprenorphine-Naloxone Treatment for Opioid Dependence in Primary Care.

Published in:

JGIM: Journal of General Internal Medicine, 2012, v. 27, n. 6, p. 669, doi. 10.1007/s11606-011-1962-8

By:

Schackman, Bruce;
Leff, Jared;
Polsky, Daniel;
Moore, Brent;
Fiellin, David

Publication type:

Article

Transdermal buprenorphine in cancer pain and palliative care.

Published in:

Palliative Medicine, 2006, v. 20, p. s25, doi. 10.1191/0269216306pm1125oa

By:

Sittl, Reinhard

Publication type:

Article

Experience with nalbuphine, a new opioid analgesic, in acute myocardial infarction.

Published in:

Journal of the Royal Society of Medicine, 1987, v. 80, n. 7, p. 418, doi. 10.1177/014107688708000708

By:

Greenbaum, R. A.;
Kaye, G.;
Mason, P. D.

Publication type:

Article

Buprenorphine alone or in combination with naloxone reducedthe use of and craving for opiates addiction: COMMENTARY.

Published in:

ACP Journal Club, 2004, v. 140, n. 3, p. 65, doi. 10.7326/acpjc-2004-140-3-065

By:

Graham, Allan W.

Publication type:

Article

Buprenorphine alone or in combination with naloxone reducedthe use of and craving for opiates in opiate addiction.

Published in:: ACP Journal Club, 2004, v. 140, n. 3, p. 65, doi. 10.7326/acpjc-2004-140-3-065
Publication type:: Article

Impact of blended treatment literacy and psychoeducation on methadone maintenance treatment outcomes in Yunnan, China.

Published in:

Harm Reduction Journal, 2016, v. 13, p. 1, doi. 10.1186/s12954-016-0097-y

By:

Bo Zhang;
Cai, Thomas;
Zhihua Yan;
Gitau Mburu;
Bangyuan Wang;
Liping Yang

Publication type:

Article

New Products & Services.

Published in:: Urology Times, 2004, v. 32, n. 9, p. 23
Publication type:: Article

Is there a ceiling effect of transdermal buprenorphine? Preliminary data in cancer patients.

Published in:

Supportive Care in Cancer, 2007, v. 15, n. 4, p. 441

By:

Patrizia Ferrera;
Patrizia Villari

Publication type:

Article

The clinical use of buprenorphine in opiate addiction: evidence and practice.

Published in:

Acta Neuropsychiatrica, 2004, v. 16, n. 5, p. 246, doi. 10.1111/j.0924-2708.2004.00095.x

By:

Law, Fergus D.;
Myles, Judy S.;
Daglish, Mark R. C.;
Nutt, David J.

Publication type:

Article

Combined Effects of Bee Venom Acupuncture and Morphine on Oxaliplatin-Induced Neuropathic Pain in Mice.

Published in:

Toxins, 2016, v. 8, n. 2, p. 33, doi. 10.3390/toxins8020033

By:

Woojin Kim;
Min Joon Kim;
Donghyun Go;
Byung-Il Min;
Heung Sik Na;
Sun Kwang Kim

Publication type:

Article

Maintenance of anaesthesia in sheep with isoflurane, desfiurane or sevoflurane.

Published in:

Veterinary Record: Journal of the British Veterinary Association, 2008, v. 163, n. 7, p. 210, doi. 10.1136/vr.163.7.210

By:

Mohamadnia, A. R.;
Hughes, G.;
Clarke, K. W.

Publication type:

Article

Sublingual administration of buprenorphine for long-term analgesia in the horse.

Published in:

Veterinary Record: Journal of the British Veterinary Association, 2007, v. 160, n. 23, p. 808, doi. 10.1136/vr.160.23.808

By:

Walker, A. F.

Publication type:

Article

Effects of two doses of buprenorphine four or six hours apart on nociceptive thresholds, pain and sedation in dogs after castration.

Published in:

Veterinary Record: Journal of the British Veterinary Association, 2006, v. 159, n. 21, p. 705, doi. 10.1136/vr.159.21.705

By:

Slingsby, L. S.;
Taylor, R M.;
Waterman-Pearson, A. E.

Publication type:

Article

Buprenorphine-Induced Antinociception Is Mediated by μ-Opioid Receptors and Compromised by Concomitant Activation of Opioid Receptor-Like Receptors.

Published in:

Journal of Neuroscience, 2003, v. 23, n. 32, p. 10331, doi. 10.1523/JNEUROSCI.23-32-10331.2003

By:

Lutfy, Kabirullah;
Eitan, Shoshana;
Bryant, Camron D.;
Yu C. Yang, Camron D.;
Nazli Saliminejad, Camron D.;
Walwyn, Wendy;
Kieffer, Brigitte L.;
Takeshima, Hiroshi;
Carroll, F. Ivy;
Maidment, Nigel T.;
Evans, Christopher J.

Publication type:

Article

Practical Synthesis and Biological Evaluation of Bergenin Analogs.

Published in:

Chemical Biology & Drug Design, 2011, v. 78, n. 4, p. 725, doi. 10.1111/j.1747-0285.2011.01194.x

By:

Jae-Chul Jung;
Eunyoung Lim;
Seung Hwan Kim;
Nam Soo Kim;
Mankil Jung;
Seikwan Oh

Publication type:

Article

Capacitive Detection of Morphine via Cathodically Electropolymerized, Molecularly Imprinted Poly( p-aminostyrene) Films.

Published in:

Macromolecular Chemistry & Physics, 2016, v. 217, n. 16, p. 1810, doi. 10.1002/macp.201600127

By:

Vergara, Aileen V.;
Pernites, Roderick B.;
Tiu, Brylee David B.;
de Leon, Al Christopher C.;
Mangadlao, Joey D.;
Binag, Christina A.;
Advincula, Rigoberto C.

Publication type:

Article

Neonatal Abstinence Syndrome Practices in the United States.

Published in:

Journal of Pediatric Pharmacology & Therapeutics, 2021, v. 26, n. 6, p. 577, doi. 10.5863/1551-6776-26.6.577

By:

Byerley, Eva M.;
Mohamed, Mohamed W.;
Grindeland, Carlina J.;
Muzzy Williamson, Julia D.

Publication type:

Article

Survey of Pain Management Therapy Provided for Children With Sickle Cell Disease.

Published in:

Clinical Pediatrics, 1992, v. 31, n. 4, p. 211, doi. 10.1177/000992289203100404

By:

Pegelow, Charles H.

Publication type:

Article

Comparison of Intrathecal Dexmedetomidine with Buprenorphine as Adjuvant to Bupivacaine in Spinal Asnaesthesia.

Published in:

Journal of Clinical & Diagnostic Research, 2014, v. 8, n. 2, p. 114, doi. 10.7860/JCDR/2014/7883.4023

By:

GUPTA, MAHIMA;
SHAILAJA, S.;
HEGDE, K. SUDHIR

Publication type:

Article

Abuse liability of intravenous buprenorphine/naloxone and buprenorphine alone in buprenorphine-maintained intravenous heroin abusers.

Published in:

Addiction, 2010, v. 105, n. 4, p. 709, doi. 10.1111/j.1360-0443.2009.02843.x

By:

Comer, Sandra D.;
Sullivan, Maria A.;
Vosburg, Suzanne K.;
Manubay, Jeanne;
Amass, Leslie;
Cooper, Ziva D.;
Saccone, Phillip;
Kleber, Herbert D.

Publication type:

Article

Problems experienced by community pharmacists delivering opioid substitution treatment in New South Wales and Victoria, Australia.

Published in:

Addiction, 2010, v. 105, n. 2, p. 335, doi. 10.1111/j.1360-0443.2009.02774.x

By:

Winstock, Adam R.;
Lea, Toby;
Sheridan, Janie

Publication type:

Article

Opioid agonist pharmacotherapy in New South Wales from 1985 to 2006: patient characteristics and patterns and predictors of treatment retention.

Published in:

Addiction, 2009, v. 104, n. 8, p. 1363, doi. 10.1111/j.1360-0443.2009.02633.x

By:

Burns, Lucy;
Randall, Deborah;
Hall, Wayne D.;
Law, Matthew;
Butler, Tony;
Bell, James;
Degenhardt, Louisa

Publication type:

Article

Comparison of costs and utilization among buprenorphine and methadone patients.

Published in:

Addiction, 2009, v. 104, n. 6, p. 982, doi. 10.1111/j.1360-0443.2009.02539.x

By:

Barnett, Paul G.

Publication type:

Article

Prevalence and clinical relevance of corrected QT interval prolongation during methadone and buprenorphine treatment: a mortality assessment study.

Published in:

Addiction, 2009, v. 104, n. 6, p. 993, doi. 10.1111/j.1360-0443.2009.02549.x

By:

Anchersen, Katinka;
Clausen, Thomas;
Gossop, Michael;
Hansteen, Viggo;
Waal, Helge

Publication type:

Article

Buprenorphine tapering schedule and illicit opioid use.

Published in:

Addiction, 2009, v. 104, n. 2, p. 256, doi. 10.1111/j.1360-0443.2008.02455.x

By:

Ling, Walter;
Hillhouse, Maureen;
Domier, Catherine;
Doraimani, Geetha;
Hunter, Jeremy;
Thomas, Christie;
Jenkins, Jessica;
Hasson, Albert;
Annon, Jeffrey;
Saxon, Andrew;
Selzer, Jeffrey;
Boverman, Joshua;
Bilangi, Richard

Publication type:

Article

The impact of methadone or buprenorphine treatment and ongoing injection on highly active antiretroviral therapy (HAART) adherence: evidence from the MANIF2000 cohort study.

Published in:

Addiction, 2008, v. 103, n. 11, p. 1828, doi. 10.1111/j.1360-0443.2008.02323.x

By:

Roux, Perrine;
Carrieri, M. Patrizia;
Villes, Virgine;
Dellamonica, Pierre;
Poizot‐Martin, Isabelle;
Ravaux, Isabelle;
Spire, Bruno

Publication type:

Article

Evaluation of a transdermal buprenorphine formulation in opioid detoxification.

Published in:

Addiction, 2007, v. 102, n. 10, p. 1648, doi. 10.1111/j.1360-0443.2007.01944.x

By:

Lanier, Ryan K.;
Umbricht, Annie;
Harrison, Joseph A.;
Nuwayser, Elie S.;
Bigelow, George E.

Publication type:

Article

Puffy hand syndrome due to drug addiction: a case–control study of the pathogenesis.

Published in:

Addiction, 2006, v. 101, n. 9, p. 1347, doi. 10.1111/j.1360-0443.2006.01521.x

By:

Andresz, Valérie;
Marcantoni, Nicolas;
Binder, Florence;
Velten, Michel;
Alt, Martine;
Weber, Jean‐Christophe;
Stephan, Dominique

Publication type:

Article

A comparison of buprenorphine and lofexidine for community opiate detoxification: results from a randomized controlled trial.

Published in:

Addiction, 2005, v. 100, n. 12, p. 1860, doi. 10.1111/j.1360-0443.2005.01273.x

By:

Raistrick, Duncan;
West, David;
Finnegan, Olwyn;
Thistlethwaite, Gill;
Brearley, Roger;
Banbery, Jo

Publication type:

Article

Opiate detoxification: what are the goals?

Published in:

2005

By:

O'BRIEN, CHARLES P.

Publication type:

Editorial

The rise of buprenorphine prescribing in England: analysis of NHS regional data, 2001–03.

Published in:

Addiction, 2005, v. 100, n. 4, p. 495, doi. 10.1111/j.1360-0443.2005.01039.x

By:

De Wet, Cornelis J.;
Reed, Laurence J.;
Bearn, Jennifer

Publication type:

Article

Buprenorphine diversion and injection in Melbourne, Australia: an emerging issue?

Published in:

Addiction, 2005, v. 100, n. 2, p. 197, doi. 10.1111/j.1360-0443.2004.00958.x

By:

Jenkinson, Rebecca A.;
Clark, Nicolas C.;
Fry, Craig L.;
Dobbin, Malcolm

Publication type:

Article

Decreasing international HIV transmission: the role of expanding access to opioid agonist therapies for injection drug users.

Published in:

Addiction, 2005, v. 100, n. 2, p. 150, doi. 10.1111/j.1360-0443.2004.00963.x

By:

Sullivan, Lynn E.;
Metzger, David S.;
Fudala, Paul J.;
Fiellin, David A.

Publication type:

Article

Screening for illicit and medicinal drugs in whole blood using fully automated SPE and ultra-high-performance liquid chromatography with TOF- MS with data-independent acquisition.

Published in:

Journal of Separation Science, 2013, v. 36, n. 13, p. 2081, doi. 10.1002/jssc.201200921

By:

Pedersen, Anders Just;
Dalsgaard, Petur Weihe;
Rode, Andrej Jaroslav;
Rasmussen, Brian Schou;
Müller, Irene Breum;
Johansen, Sys Stybe;
Linnet, Kristian

Publication type:

Article

Synthesis of potential buprenorphine intermediates by selective microbial N- and O-demethylation.

Published in:

Biotechnology Letters, 2002, v. 24, n. 15, p. 1291, doi. 10.1023/A:1016218211300

By:

Abel, Anthony M.;
Carnell, Andrew J.;
Davis, J. Alf;
Paylor, Michael

Publication type:

Article

Effects of quercetin on chronic constriction nerve injury in an experimental rat model.

Published in:

Acta Neurochirurgica, 2016, v. 158, n. 5, p. 959, doi. 10.1007/s00701-016-2761-0

By:

Çivi, Soner;
Emmez, Gökçen;
Dere, Ümit;
Börcek, Alp;
Emmez, Hakan

Publication type:

Article

High Dose Transdermal Buprenorphine for Moderate to Severe Pain in Spanish Pain Centres—A Retrospective Multicenter Safety and Efficacy Study.

Published in:

Pain Practice, 2008, v. 8, n. 5, p. 355, doi. 10.1111/j.1533-2500.2008.00205.x

By:

Barutell, Carlos;
Camba, Alberto;
González-Escalada, José-Ramón;
Rodríguez, Manuel

Publication type:

Article

Identification of an additional supraspinal component to the analgesic mechanism of action of buprenorphine.

Published in:

2009

By:

Zhe Ding;
Raffa, Robert B.;
Ding, Zhe

Publication type:

journal article

Satisfaction guaranteed? What clients on methadone and buprenorphine think about their treatment.

Published in:

Drug & Alcohol Review, 2008, v. 27, n. 6, p. 671, doi. 10.1080/09595230801935706

By:

MADDEN, ANNIE;
LEA, TOBY;
BATH, NICKY;
WINSTOCK, ADAM R.

Publication type:

Article

Mortality related to pharmacotherapies for opioid dependence: a comparative analysis of coronial records.

Published in:

Drug & Alcohol Review, 2007, v. 26, n. 4, p. 405, doi. 10.1080/09595230701373834

By:

Gibson, Amy E.;
Degenhardt, Louisa J.

Publication type:

Article

Naltrexone implant treatment for buprenorphine dependence – Mauritian case series.

Published in:

Journal of Psychopharmacology, 2014, v. 28, n. 8, p. 800, doi. 10.1177/0269881114528592

By:

Jhugroo, Anil;
Ellayah, Darmen;
Norman, Amanda;
Hulse, Gary

Publication type:

Article